Viral vector vaccines receive far less attention, but they merit serious consideration because they hold much promise for mitigating infectious diseases.
/PRNewswire/ ReiThera, a biotech company dedicated to the development of new technologies, GMP production and the clinical translation of genetic vaccines.
- New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; - New facility will allow ReiThera
/PRNewswire/ ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and.
/PRNewswire/ ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and.